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Abstract: Novel antiviral approaches are needed to control Hepatitis B virus infection worldwide. X protein of this virus 
activates various promoters and is strongly associated with hepatocellular carcinoma. Although several groups, including 
ours, reported sequence-specific cleavage of X RNA by either ribozymes (Rzs) or DNA-enzymes (Dzs) earlier, but none 
of these studies reported 100% in vitro cleavage of the full-length X RNA. We reasoned that by melting the secondary 
structures near the Rz/Dz cleavage site with specific antisense DNA oligonucleotides (ODNs) or 10-23 Dz, it may be pos-
sible to achieve this objective. Hammerhead motif containing Rz-170 specific for X RNA was constructed by recombinant 
techniques and Dz-237 was synthesized using the 10-23 catalytic motif. When specific ODNs or 10-23 Dzs were included 
in the cleavage reaction with either Rz-170 or Dz-237, increased cleavage was observed in a dose-dependent manner 
which often resulted in almost complete in vitro cleavage of the target RNA. Rz-170 in combination with specific ODNs 
caused potent intracellular reduction of HBx RNA. Thus, the cleavage activity of catalytic nucleic acids (Rzs or Dzs) can 
be increased significantly by specific ODNs or Dzs and this treatment also results in potent intracellular target RNA re-
duction. These findings have important therapeutic implications. 
INTRODUCTION 
 Ribozymes (Rzs) are short catalytic RNA molecules that 
possess the ability to cleave the target RNA in a sequence-
specific manner and control splicing reactions (Cech, 1987) 
[1,2,3,4]. Although several types of catalytic motifs have 
been described, the hammerhead Rz being the smallest and 
with minimal target sequence requirement, has been ex-
ploited extensively for variety of purposes including thera-
peutic applications [5,6,7,8]. On the other hand, Deoxyri-
bozymes or DNA-enzymes (Dzs), as originally [9] are short 
DNA molecules that can be designed to cleave any target 
RNA in a sequence-specific and catalytic manner [10,11,12]. 
Over the years several kinds of Dzs with unique catalytic 
motifs have been described but Dz possessing the 10-23 
catalytic motif has been exploited extensively by several 
investigators [11]. This Dz possesses a conserved 15 nucleo-
tide long 10-23 catalytic motif and is able to cleave any tar-
get RNA between purine and pyrimidine under in vitro and 
in vivo conditions. Their ability to cleave any target RNA 
has been exploited for knocking down gene expression 
against variety of target genes including HIV-1 genes 
[11,13,14] with varying outcomes. In some instances very 
efficient intracellular gene inhibition was observed with 10-
23 Dz [15]. We also reported earlier that 10-23 Dz was more 
effective in cleaving the full-length CCR5 (HIV-1 corecep-
tor) RNA compared to a hammerhead ribozyme [16,17] car-
ried out a comparative study between hammerhead ri-
bozymes (Rzs) and Dzs that were targeted against the same 
sequences and concluded that some sequences were cleaved 
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better by Rzs and some by Dzs. There are several other nu-
cleic-acid based approaches that have been used for specific 
inhibition of target genes. The catalytic ribozymes, aptamers, 
antisense DNA or RNA or small interfering RNAs (siRNAs) 
have been used for inhibiting the expression of foreign genes 
including HIV-1 replication [8]. Physiologically relevant 
RNAs are usually long and consist of multiple stem-loop 
structures and up to 90% putatitive cleavage sites were ear-
lier shown to be in inaccessible to either Rz or Dz mediated 
cleavage [18]. Earlier, unwinding activity of an RNA heli-
case was used to increase the cleavage potential of Rzs [19]. 
Collectively, all these studies suggest that not all the target 
sites are available for cleavage by a single kind of catalytic 
nucleic-acid molecule most probably because the secondary 
and tertiary structures in the target RNA prevent optimal 
Watson-Crick base pairing with Rzs or Dzs. Introduction of 
locked nucleic-acids in antisense design resulted in enhanc-
ing its stability [20] and when incorporated in the substrate 
recognition arms of a Dz, it improved the catalytic efficiency 
[21].  
 Earlier few nucleic-acid based approaches were used to 
modulate the cleavage activity of the Dzs and Rzs with mod-
erate success but none of them were tested for bio-efficacy. 
Oligonucleotide effectors (regulators) that bind to both en-
zyme and substrate were used to regulate the catalytic activ-
ity of Rzs & Dzs [22, 23]. Whether oligodeoxynucleotides 
(ODNs) that hybridize specifically to the target RNA alone 
could modulate in vitro and in vivo the catalytic activity of 
Rzs or Dzs have not been earlier attempted.[24] reported 
enhancement of ribozyme catalytic activity by a contiguous 
oligonucleotide (facilitator) and by 2’-O-methylation. Oli-
gonucleotide facilitators have been used to either enhance  
 
2    The Open Biotechnology Journal, 2008, Volume 2 Gupta et al. 
[25] or even inhibit catalytic activity of Rzs [26]. We re-
cently reported Dz mediated augmentation of in vitro cleav-
age of a truncated HIV-1 Gag gene by specific antisense 
molecules [27]. Oligonucleotide facilitators have earlier been 
used to enhance hammerhead ribozyme mediated cleavage of 
long RNA substrates with multiple-turnover activity [28]. 
Although all the above approaches resulted in enhanced 
cleavage of the target RNA under in vitro conditions, it was 
not known if combinations of ribozymes or DNA-enzymes 
with facilitators could be exploited to down regulate intracel-
lular levels of the target RNAs. 
 In the present study, we have identified and characterized 
those ODNs and Dzs that significantly enhanced the Rz and 
Dz mediated cleavage of full-length X RNA (HBx RNA) of 
hepatitis B virus (HBV) on one hand and inhibit intracellular 
expression of the target RNA in a liver specific cell line, 
HepG2 on the other. The Hepatitis B virus X protein (HBx) 
acts as a powerful transactivator for several genes including 
HBV genes and is known to be strongly associated with he-
patocellular carcinoma [29, 30]. These results are potentially 
important for therapeutic purposes for the treatment of HBV 
infections against which there are no effective antiviral 
treatment available. 
METHODOLOGY 
Cloning of HBx Gene and In Vitro Transcription 
 Plasmid pSG5.HBx encoding the X gene of HBV [31] 
was a kind gift from Vijay Kumar, ICGEB, New Delhi, In-
dia. The entire gene is placed under SV40 and T7 promoters 
(Fig. 1). The former promoter is used for intracellular ex-
pression and the latter was used for obtaining in vitro tran-
scripts using the transcription kit from Promega Biotech., as 
described earlier [32]. After linearization with appropriate 
enzyme at the 3’-end, full-length X RNA will be synthe-
sized.  
Construction and Cloning of HBx-Rz-170 Targeted 
Against X Gene 
 The construction of Rz-170 (Fig. 2A) has been described 
by us in detail previously [33]. It possessed the hammerhead 
motif and targeted against the GUC sequence. EcoR1 and 
BamH1 restriction sites were engineered at the ends of the  
 
hybridizing arms of the Rz which facilitated cloning it into 
pcDNA3 expression vector (Promega). This placed the Rz 
under T7 and CMV promoter. 
In Vitro Cleavage of Target RNA with Rz  
 In vitro transcription of the linearized plasmid DNA was 
carried out in the presence of labeled UTP using T7 RNA 
polymerase. The cleavage reaction was initiated by adding 
equimolar amounts (100 pmoles each) of the labeled target 
RNA and unlabeled Rz in a reaction buffer containing 
50mM Tris/HCl, pH 7.5, in a volume of 10?l. The reaction 
mixture was heated briefly at 94
o
C and the cleavage reaction 
was initiated by adding MgCl2 (final concentration 10mM) at 
37
o
C for 2 hours. The cleaved RNA fragments were sub-
jected to gel analysis as described before [34]. The radioac-
tive RNA bands on the X-Ray film were quantitated by den-
sitometry (GS-710 Calibrated Imaging Densitometer, Bio-
Rad, Hercules, CA, USA). 
Primers & DNA-Enzyme 
 All the 20nt long antisense oligonucleotides (ODNs) 
were synthesized chemically and obtained from Sigma 
Genosys (The Woodlands, TX). The conserved 15 nt long 
(5’-GGCTAGCTACAACGA) 10-23 catalytic motif was 
flanked on both sides by substrate-binding arms of the Dz 
that were made complementary to the target RNA. We have 
earlier described in detail the construction of Dz-237 that 
cleaved the X RNA specifically into two fragments (Fig. 2B) 
[35]. Dz-155, wild-type and mutant versions of Dz-192 were 
also assembled using 10-23 catalytic motif that possessed a 
single nucleotide substitution (G to C) in the 10-23 catalytic 
motif (Fig. 3B). This change is known to render the Dz cata-
lytically inactive [35].  
Dz-Mediated Cleavage 
 Equivalent amounts of unlabeled Dz and labeled sub-
strate RNA (100 pmoles each) were allowed to interact in a 
final volume of 10?l in a buffer containing 50mM Tris.HCl, 
pH 7.5 in presence of 10mM MgCl2 (standard conditions) as 
described earlier [9] for 2 hours at 37
o
C in the absence or in 
the presence of indicated amounts of ODNs. The cleaved 
products were resolved by gel analysis and cleavage effi-
ciency was determined as described earlier [34, 35].  
 
 
 
 
 
 
Fig. (1). Full-length HBx encoding DNA and in vitro transcription. 
Plasmid pSG5.HBx (Kumar et al., 1996) contains the full length X gene of hepatitis B virus. It is placed downstream of the powerful SV40 
and T7 promoter of the expression vector pSG5 (Clonetech, Palo, Alto, CA, USA). After linearizing it with Bgl II restriction enzyme, a 465nt 
long transcript is generated by in vitro transcription using T7 RNA polymerase.  
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Intracellular Inhibition of the Expression of Target RNA 
by Rz + ODNs 
 The intracellular decrease in HBx-specific RNA after 
cotransfection into HepG2 cells with substrate encoding 
DNA (pSG5.HBx) + Rz in the presence or absence of ODNs 
were monitored by RT-PCR based assays. To ensure uni-
form transfection efficiency, we always transfected equal 
amounts of reporter gene containing plasmid (pSV-?-gal, 
Promega). We repeatedly obtained about 70 – 80% transfec-
tion efficiency. All the plasmid DNAs used was Qiagen col-
umn purified which showed no toxicity under our experi-
mental conditions. Several dilutions were initially made to 
determine the linear range for PCR-amplified products. Total 
RNA was isolated using TRIZOL reagent (GIBCO-BRL) 
following the procedure described by the manufacturer and 
divided into two equal sets. One set was used for estimating 
the levels of full-length X RNA using HBx1 and HBx2 
primers and the second set was used for estimating the levels 
of the house keeping gene, human glyceraldehyde-phospho- 
dehydrogenase (HuGAPDH) as described earlier [36]. The 
following primers were used for estimating the intracellular 
levels of full-length X RNA.  
(1) Forward (HBx1): 5’-TTAGGCAGAGGTGAAAAAGTT 
GCATGGTGCTGG .  
(2) Reverse(HBx2):5’- TGGCTGCTAGGCTGTACTGCCA 
ACTGGATCCTTCG 
Western Blot Analysis 
 1 x 10
6
 HepG2 cells were grown to 80% confluency in a 
six well plate. They were transfected with either Rz-170 
(1?g /ml) alone or in the presence of increasing concentra-
tions of ODN #1 and # 2 in a final volume of 1ml for 48 
hours along with 1?g of X gene encoding DNA, pSG5.HBx, 
using lipofectin (Invitrogen). Cell lysates were prepared and 
equivalent amounts of proteins were loaded in each lane as 
described earlier [35, 33]. They were subjected to gel analy-
sis and transferred on to a nitrocellulose membrane. Rabbit 
polyclonal antibody to HBx (Biovendor, NJ, USA) was used 
as a primary antibody in 1:500 dilution in PBS pH 7.2 con-
taining 0.1% Tween 20. For ?-actin as control, mouse raised 
monoclonal antibody (Calbiochem, CA ,USA) was used as 
primary with 1:10,000 dilution in PBS-T. The amounts of 
pSG5.HBx DNA was kept constant in each experimental 
lane at 1?g/ml. The absolute amounts of DNA introduced in 
each well was made equivalent by adding unrelated DNAs.  
Inhibition of X Protein Mediated HIV-1 LTR Activation 
with Rz and ODNs or Dzs 
 HEK 293 or HepG2 cells were cotransfected with 100 ng 
of pBS-LTR-B-Luciferase (henceforth referred to as pLTR-
B – the Luciferase reporter gene is placed down stream of 
the HIV-1 LTR-B promoter) (obtained from AIDS Research 
and Reference Reagent Program of NIH, MD, USA) plasmid 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Sequence of the target RNA against which Rz-170 and Dz-237 were designed are shown along with their specific cleavage 
products. 
For constructing Rz-170, eight bases long hybridizing arms are made complementary to the target RNA to provide specificity (Panel A). The 
hammerhead catalytic motif is same as described before (Shahi et al., 2001). The site of cleavage in the target RNA is shown by an arrow. 
When the full length HBx RNA is subjected to cleavage by Rz-170 in presence of MgCl2, two specific RNA fragments are expected that 
are170 and 295nt long. Panel B: 10-23 catalytic motif containing Dz-237 was chemically synthesized that targeted AU dinucleotide in the 
target RNA for cleavage. 7 bases long hybridizing arms were made complementary to the target RNA to provide specificity. The expected 
cleavage products generated due to the action of Dz are shown. 
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in the presence of indicated amounts of ODNs or Dzs in 
wells that received 100 ???ng of pSG5.HBx plasmid DNA that 
was kept constant in all the wells. Lipofectin was used to 
introduce the mixture of various DNA combinations and cell 
lysates were prepared 24 hours later using 1x reporter lysis 
buffer (Promega). The extent of Luciferase activity was de-
termined according to the manufacturer’s instructions 
(Promega). A control reporter plasmid (pSV-?-gal, Promega) 
was always included to ensure uniform transfection effi-
ciency. 
RESULTS 
In Vitro Synthesis of Full-Length HBx RNA by T7 RNA 
Polymerase  
 Plasmid pSG5-HBx (Fig. 1) was linearized with Bgl II 
restriction enzyme and when subjected to in vitro transcrip-
tion using T7 RNA polymerase, a 465nt long full-length 
HBx transcript is expected using the Riboprobe transcription 
kit (Promega Biotech., WI, USA) in the presence of 
32
P 
UTP. Transcripts were subjected to gel analysis and dried 
gels were exposed to X Ray. 
Rz-170 Mediated Cleavage of HBx RNA in the Presence 
of Upstream and Downstream ODNs  
 Entire sequence of the Rz-170 along with the target RNA 
is shown in Fig. (2A). The target sequence was GUC located 
at nucleotide position 170 in the HBx gene. The 22nt long 
hammerhead motif was flanked with eight nucleotides long 
hybridizing arms on either side of the target sequence that 
were made complementary to the target RNA to provide 
specificity. When an equimolar amount (100pmoles each) of 
Rz-170 is used for cleaving a full-length HBx RNA (465nt), 
specific RNA fragments (170 and 295 bases long) are ex-
pected (Fig. 2A). In order to increase the Rz-170 mediated 
cleaved products, 3 antisense ODNs, each 20nt long, were 
synthesized. Two of these ODNs (#1 & #2) were designed to 
hybridize immediately adjacent to the two hybridizing arms 
of the hammerhead Rz-170. We designed another ODN 
(ODN#3) that was 33 nt upstream from the Rz-170 cleavage 
site (Fig. 3, panel A). In the similar manner, 10-23 catalytic 
motif containing Dzs were synthesized immediately up-
stream and downstream of the Rz-170. Exact sequence of 
these Dzs along with the mutant (disabled Dz-192) is shown 
in Fig. (3, panel B). Rz-170 mediated cleavage reaction was 
performed in the presence of indicated amount of ODNs 
individually and the results are shown in Fig. (4A). Lane 1 
shows the synthesis of uniformly labeled full-length (465nt 
long) HBx RNA. When equimolar amounts (100 pmoles 
each) of Rz and labeled substrate RNA were used for cleav-
age under standard conditions [7, 12, 31], two specifically 
cleaved fragments (295 and 170nt long RNA fragments) 
were obtained (lane 2). When the same cleavage reaction 
was carried out in the presence of 10pmoles (lane 3); 
50pmoles (lane 4); and 100pmoles (lane5) of ODN#1, a 
dose-dependent decrease in the input substrate RNA was 
observed. Approximately 4-fold decrease was observed in 
the input substrate RNA when lane 5 was compared with 
lane 2, and 2.5 fold reduction when lanes 3 and 4 were com-
pared with lane2 (Fig. 4A). In the similar manner, the 
ODN#2 also caused a dose-dependent decrease in the sub-
strate RNA when similar amounts were used (10pmoles –
lane 6; 50pmoles – lane 7; 100pmoles – lane 8). Note almost 
complete disappearance of the input substrate RNA in lane 8. 
We conclude that ODNs that hybridized immediately up-
stream and downstream of Rz-170, were able to significantly 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). ODNs and Dzs designed to augment Rz-170 mediated cleavage products. 
Panel A: Three 20 nucleotides long antisense oligodeoxynucleotides (ODNs) (#1 to # 3) were synthesized. Two of them (ODN #1 and 2) 
were targeted to hybridize immediately next to the hybridizing arms of the Rz-170 and their sequences are shown. ODN #3 was 33nt away 
from the Rz cleavage site and its sequence is also shown. All the oligonucleotides were chemically synthesized and obtained from Sigma 
Genosys. Panel B: Two Dzs (Dz-155 and 192) possessing 10-23 catalytic motif, were synthesized immediately upstream and downstream of 
Rz-170. A mutant (disabled) version of Dz-192 was synthesized by substituting a C residue in place of G in the catalytic motif.  
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augment the Rz-170 mediated cleavage and that ODN#2 was 
more effective than ODN#1. 
Antisense ODN #3 Targeted to Hybridize 33nt Away 
from the Rz-170 Cleavage Site Fails to Augment its 
Cleavage  
 The nature of the experiment is same as described in Fig. 
(4A). Briefly, Rz-170 mediated cleavage of the target RNA 
(Fig. 4B, lane 1) was studied in the presence of increasing 
amounts of ODN#3 (Fig. 3A) and the results are shown in 
Fig. (4B). Lane 2 exhibits the cleavage obtained with equi-
molar amounts (100pmoles) of labeled substrate and Rz-170. 
When increasing amounts of ODN#3 (1pmole – lane 3; 
10pmole – lane 4; 100pmoles – lane 5 and 200pmoles – lane 
6) were included in the cleavage reaction, the extent of 
cleavage remained unchanged. We conclude that ODN that 
hybridized 33nt upstream from the Rz-170 cleavage site 
failed to augment Rz-170 mediated cleavage.  
A. B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4A). Augmentation of Rz-170 mediated cleavage by specific ODNs. 
ane 1 shows the synthesis of uniformly labeled 465nt long HBx RNA. When equimolar amounts (100pmoles each) of substrate and Rz-170 
were mixed in presence of 10mM MgCl2, specific cleavage products (295 and 170nt long RNA fragments) were observed (lane 2). When the 
same cleavage reactions were carried out in presence of increased amounts of ODN #1 (10 pmoles – lane 3; 50 pmoles –lane 4; 100 pmoles –
lane 5) or ODN #2 (10 pmoles –lane 6; 50 pmoles –lane 7 and 100 pmoles –lane 8), a significant reduction in the input substrate RNA was 
observed with concomitant increase in the cleavage products.  
Fig. (4B). ODN#3 fails to augment Rz-170 mediated cleavage products. 
When the same substrate RNA (lane 1) was subjected to Rz-170 mediated cleavage in the presence of increasing amounts of ODN #3 (lane 3 
-1pmole; lane 4 -10pmoles; lane 5 – 100pmoles and lane 6 -200pmoles), no significant increase in the cleavage products were observed when 
compared with Rz-170 mediated cleavage only (lane 2). 
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Only Downstream Dz (Dz-192) Significantly Enhanced 
Rz-170 Mediated Cleavage 
 Since we observed significant enhancement of Rz-170 
mediated cleavage products by the two ODNs (#1 & #2) that 
hybridized immediately upstream and downstream to the 
hybridizing arms of the Rz, we wanted to find out if the two 
Dzs (Dz-155 and Dz-192) that were designed in a similar 
manner (Fig. 3B) could also enhance the Rz-170 mediated 
cleavage. The various cleavage products (including partially 
cleaved products) that are expected due to the combined ac-
tions of Rz + Dz-155 and Rz + Dz-192 are shown schemati-
cally in Fig. (5). The reaction conditions were same as de-
scribed for Fig. (4A) and the results are shown in Fig. (6A). 
Lane 1 shows the labeled full-length in vitro synthesized 
HBx RNA as described earlier. Lane 2 shows sequence-
specific cleavage of the target RNA when equimolar 
amounts of Rz were used. In presence of increasing amounts 
of Dz-155 (lane 3 -10pmole; lane 4 – 50pmoles; lane 5 – 
100pmoles), no significant reduction in the amounts of input 
substrate RNA was observed. Lane 3 and 4 show no de-
crease but lane 5 shows 1.5 fold decrease when compared 
with lane 2. On the other hand when the cleavage reaction 
was carried out in presence of increasing amounts of Dz-192 
(lane 6 – 10 pmoles; lane 7 – 50 pmoles and lane 8 -
100pmoles), a dose-dependent decrease in the input substrate 
RNA was observed with almost complete disappearance at 
50 and 100pmoles of Dz-192. Lane6 shows 4 folds, lane7 
shows 5 folds and lane 8 shows 5.5 folds decrease when 
compared with input substrate RNA present in lane2 (Fig. 
6A). We conclude that only the downstream Dz-192 was 
able to significantly enhance the Rz-170 mediated cleavage.  
Wild-Type & Mutant Dz-192 Augment Rz-170 Mediated 
Cleavage  
 The purpose of this experiment was to compare augmen- 
tation of the Rz-170 mediated cleavage between the wild-
type and mutant-Dz-192 (disabled). As reported earlier, this 
mutant Dz [35] failed to cleave the target RNA completely 
and served as an important antisense control for the wild-
type Dz. Exactly same amounts of wild-type (Dz-192) and 
mutant-Dz-192 were added to the cleavage reaction which 
contained equimolar amounts of Rz-170 and Substrate RNA. 
The results of this experiment are shown in Fig. (6B). Lane 1 
is the HBx transcript and when cleavage reaction was carried 
out with Rz-170 alone (lane 2), two specific fragments were 
seen as described before. When the Rz-170 mediated cleav-
age reaction was carried out in the presence of increasing 
amounts of Dz-192 (lane 3 -1pmole; lane 4 -10pmoles and 
lane 5 -100pmoles), a dose-dependent decrease in the sub-
strate RNA was observed along with multiple cleaved frag-
ments. These fragments match the predicted pattern of cleav-
age described earlier (Fig. 5, steps C and D). The same ex-
periment was carried out with increasing amounts of Mutant-
Dz-192 under identical conditions of cleavage (lane 6 -
1pmole; lane 7 -10pmoles and lane 8 -100pmoles). In this 
case also a dose-dependent decrease in the input substrate 
RNA was observed. In both cases, up to 8 – 10 fold decrease 
in the input labeled substrate RNA was observed in the pres-
ence of highest amounts of Dz used (compare the extent of 
uncleaved input substrate RNA in lanes 1, 5 and 8). Since 
this mutant-Dz is catalytically inactive, no additional cleaved 
products were observed. The extent of reduction in the input 
RNA with either wild-type (WT) or mutant-Dz in corre-
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (5). Modulation of Rz-170 mediated cleavage products with Dzs. 
Full-length HBx RNA was used as target RNA for cleavage with Rz-170 in the presence of upstream (Dz-155) and downstream Dz (Dz-
192). The expected cleavage pattern generated by cleavage with Rz, Dz and Rz + Dz is shown schematically in Fig. (6) (steps marked A to D). 
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sponding lanes were very similar. This indicated that the 
reduction in the input substrate RNA is mainly due to an-
tisense effect and not because of catalytic activity. We con-
clude that both wild-type and mutant Dz-192 increased the 
Rz-170 mediated cleavage products to similar extent.  
HBx-Dz-237 Mediated Cleavage is Enhanced Moderately 
by Upstream but Powerfully by Downstream ODN  
 All the earlier experiments described above were de-
signed to increase the cleavage of Rz-170 and we next 
wanted to know if the earlier identified Dz against HBx 
RNA, Dz-237 [35] could also be modulated by using 20nt 
long upstream or downstream ODNs (Fig. 7A). The cleavage 
results of this experiment are shown in Fig. (7B). Lane 1 is 
the input substrate HBx RNA and lane 2 shows the Dz-237 
mediated specific cleavage products (237 & 228nt long RNA 
fragments). In the presence of increasing amounts of up-
stream ODN (ODN#4) (lane 3 -10pmoles; lane 4 – 
100pmoles; lane 5 -200 pmoles), only about 2 fold decrease 
in the amounts of uncleaved substrate RNA was observed 
with 200pmoles of ODN# 4 (compare lane 4 with lane 2). 
When the same reaction was carried out in the presence of 
increasing amounts of downstream ODN (ODN# 5) (lane 6 -
10 pmoles; lane 7 -100pmoles; and lane 8 -200pmoles), sig-
nificant reduction in the substrate RNA was observed (> 20 
fold reduction) with almost complete disappearance in the 
presence of 200pmoles of ODN# 5 lane 8. We conclude that 
downstream ODN is significantly more effective in enhanc-
ing the Dz-237 mediated cleavage reaction.  
A. B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (6A). Downstream Dz (Dz-192) augments Rz-170 mediated cleavage very significantly. 
Rz-170 mediated cleavage reaction was performed in the presence of Dz-155 and 192 in increasing concentrations. Lane 1 shows the HBx 
RNA (465nt). As expected, Rz-170 reaction generated two specific fragments (lane 2). When increasing concentration of Dz-155 (lane 3 -
10pmoles; lane 4 -50pmoles; lane 5 -100pmoles) was used in the reaction, no significant enhancement of cleavage was observed (lanes 3 -5). 
On the contrary increasing amounts of Dz-192 (lane 6 -10pmoles; lane 7 -50pmoles and lane 8 -100pmoles) was very effective in cleaving 
the target RNA (as evident by the reduced amounts of input RNA remaining in lane 7 and 8).  
Fig. (6B). Both wild-type and mutant Dz-192 show increased cleavage of the target RNA. 
The purpose of this experiment was to compare the ability of catalytically active and inactive Dz-192 in their ability to augment Rz-170 
cleavage of the target RNA (lane 1) under exactly identical conditions. Lane 2 depicts the extent of cleavage obtained with Rz-170 alone. 
When increasing amounts of Dz-192 (lane 3 -1pmole; lane 4 – 10pmoles; lane 5 -100pmoles) was added to the reaction mixture, a dose-
dependent increase in the cleavage products was observed that matched the predicted pattern as shown in Fig. (5D). In the same manner, in 
presence of increasing amounts of mutant-Dz-192 (lane 6 – 1pmole; lane 7 -10pmoles; lane 8 -100pmoles), also resulted in dose-dependent 
cleavage of the substrate RNA.  
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Rz-170 + ODNs Treatment Results in Potent Intracellu-
lar Reduction of Target RNA 
 HepG2 cells were cotransfected with 1?g each of 
pSG5.HBx DNA and Rz-170 construct in one ml for 48 
hours using 10?l of Lipofectin (Invitrogen). This dose was 
predetermined to give about 10% intracellular reduction in 
the levels of target RNA (Fig. 8, lane 4) when compared 
with cells transfected with pSG5.HBx DNA alone along with 
A. 
 
 
 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (7A). ODNs designed for augmenting Dz-237 mediated cleavage. 
Dz-237 was used to cleave the target RNA in the presence of either ODN #4 or 5. The sequences of the two ODNs flanking the hybridizing 
arms of the Dz-237 are also shown along with the expected cleaved fragments. Panel 7B: Lane 1 is the substrate RNA and lane 2 exhibits the 
cleavage products due to Dz-237 cleavage. In the presence of increasing concentrations of ODN#4 (lane 3 – 10pmoles; lane 4 -100pmoles; 
lane 5 -200pmoles), a dose-dependent decrease in the input substrate RNA was observed. Similar observations were made with ODN# 5 but 
it was more effective in decreasing the input substrate RNA when used in increasing amounts (lane 6 -10pmoles; lane 7 -100pmoles and lane 
8 – 200pmoles).  
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equal amounts of unrelated Rz (lane 3). Total RNA was iso-
lated using TRIZOL and target RNA and control RNA were 
estimated simultaneously by RT-PCR technique. When 4?g 
of ODN #2 was added to the Rz-170 construct + 
pSG5.HBx.DNA mixture (lane 5), approximately 70% re-
duction was observed (compare lane 5 with lane 3). When 
the same amount of ODN #1 was used, about 20% reduction 
was observed (lane 6). When half the above amount of ODN 
#1 & #2 (2?g each) were used, about 50% reduction in the 
target RNA was observed (compare lane 7 with lane 3). RT-
PCR carried out with cells only (lane 2) and RT-PCR carried 
out in the absence of RT (data not shown), as expected, 
showed no HBx RNA specific amplification. The extent of 
house keeping gene (HuGAPDH) in all the corresponding 
lanes remained essentially unchanged. We conclude that Rz-
170 + downstream ODN combination was more effective in 
causing decrease in the levels of intracellular target RNA. 
 
 
 
 
 
 
 
 
 
 
Fig. (8). Intracellular reduction of target RNA in the presence 
of Rz + ODNs. 
Estimation of target RNA (HBx RNA) in HepG2 cells treated with 
various combinations of Rz and Rz + ODN #1 and #2 by RT-PCR 
techniques. The levels of full-length X RNA and control RNA 
(HuGAPDH) were determined simultaneously by RT-PCR as de-
scribed in materials and methods. Wells that received 1 μg of 
pSG5.HBx DNA + equivalent amounts of unrelated ODN of similar 
length, showed a prominent X gene-specific band. This amount was 
kept constant in all the wells. Cells were cotransfected with 1μg 
each of Rz-170 + pSG5.HBx DNA (lane 4); pSG5.HBx +1μg Rz + 
4μg of ODN #2 (lane 5); pSG5.HBx +1μg Rz + 4μg of ODN #1 
(lane 6); pSG5.HBx +1μg Rz + 2μg of ODN #1 + 2μg of ODN #2 
(lane 7).  
Western Blot Analysis  
 HepG2 cells cotransfected with Rz + ODNs were proc-
essed for total protein and subjected to western blot analysis 
as described before [35,33] and the results are shown in Fig. 
(9). Lane 1 represents control cells only. A prominent im-
munoreactive HBx protein was observed (lane 2) when 
transfected with 1?g each of pSG5.HBx plasmid DNA. 
About 2-fold reduction in the HBx protein band was ob-
served when cells were cotransfected with 1?g each of 
pSG5.HBx plasmid DNA and Rz-170 DNA (lane 3). When 
ODN # 1 and #2 (4?g in one ml) were also included, a com-
plete knock down of the HBx protein was observed (lanes 4 
& 5). This is not due to unequal amounts of cell lysates that 
were analyzed because equivalent amounts of cells contain-
ing same amounts of total protein were loaded (as deter-
mined by colorimetric reaction with BCA reagent from 
Pierce). We conclude that both the ODNs in combination 
with Rz-170 caused complete intracellular reduction in the 
levels of X protein.  
Potent Knock Down of HBx Mediated HIV-1 LTR Re-
porter Gene Activation by Rz-170 + ODNs or 10-23 Dz 
 HepG2 cells were cotransfected with pSG5.HBx + p-
LTR-B plasmid DNA (100 ng each in one ml for 1X 10
6
 
cells) along with indicated amounts of ODNs or Dz and the 
reporter gene activity (luciferase) (mean +/- SD) obtained 
from three independent experiments are shown in Fig. (10). 
As expectd HBx encoding DNA showed significant LTR-
promoter activity (compare lane 4 with lane 3). This activity 
diminished more than 2.4-fold when 100ng of Rz-170 was 
added (lane 5). Upon addition of ODN#1, it dropped 8.4 fold 
(lane 6), with ODN#2 about 5.8 fold (lane 7) and in combi-
nation of both about 8.4-fold (lane 8). Control cells and 
pSG5.HBx treated cells showed no significant reporter gene 
activity as expected (lanes 1 & 2). Thus, an additional 3 - 4 
fold decrease (when compared with Rz-170 alone) in X gene 
mediated reporter gene activity with ODN #1 is observed. 
More than 17-fold reduction in reporter gene activity was 
observed with Dz-192 under identical conditions (lane 9) and 
about 12.6-fold reduction with the mutant version of Dz-192 
(lane 10). We conclude that ODNs (#1 & #2), wild-type and 
mutant Dz-192 treated cells showed impressive functional 
inhibition of HBx protein. As expected Dz-192 (lane 11) and 
mutant Dz-192 (lane 12) showed significant reduction in 
reporter gene activity.  
 
 
 
 
Fig. (9). Intracellular reduction in the levels of X protein by western-blot analysis. 
HepG2 cells were transfected with pSG5.HBx plasmid alone (lane 2); cotransfected with pSG5HBx + Rz-170 construct (lane 3); pSG5HBx 
+ Rz-170 construct + ODN #1 (lane 4); pSG5HBx + Rz-170 construct + ODN #2 (lane 5) with indicated amounts (see result section). The 
total amount of DNA used in each well was kept constant by adding unrelated or unrelated ODNs of similar length. Cell lysates were pre-
pared from equivalent amount of cells and subjected to western blot analysis as described before.  
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DISCUSSION 
 Efficient cleavage of a target RNA by Rz or Dz is impor-
tant for several reasons including biochemical and gene ther-
apy approaches. Although there are several potential Dz or 
Rz target sites in a target RNA, most of them are cleaved 
poorly or not at all when tested on longer and physiologi-
cally relevant RNAs. We report that ODNs that were tar-
geted to hybridize directly adjacent to the Rz or Dz target 
sites were able to significantly augment Rz or Dz mediated 
cleavage activity in dose-dependent manner and that the 
downstream Dz or ODNs usually worked better than the 
upstream Dz. In both the cases (Rz + ODNs or Dz + ODNs) 
almost complete cleavage of the target RNA was achieved 
under defined set of conditions. Showing close to 100% in 
vitro cleavage of the target RNA with Rz or Dz in the pres-
ence of specific ODNs or Dz on one hand and potent intra-
cellular reduction in a mammalian liver-specific cell line on 
the other are the major findings of the present work. It must 
be emphasized that all the previous studies that employed 
either Rz or Dz alone, complete in vitro disappearance of the 
input substrate RNA was never achieved under standard 
conditions of cleavage. This data assumes more significance 
because ODNs and Dzs are currently being exploited for 
therapeutic purposes [6, 11]. The most likely explanation for 
enhanced cleavage by Rz or Dz with specific ODNs is their 
ability to melt the secondary structure near the Rz and Dz 
target sites which facilitated efficient hybridization between 
Rz-170 or Dz-237 with HBx RNA. This ODN mediated en-
hancement of cleavage was not observed with unrelated 
ODN of similar length (data not shown) or with ODN that 
hybridized 33nt upstream of the target RNA. This is most 
probably because long RNAs are known to exist in separate 
stem-loop structures or independent domains. Results with 
upstream and downstream (wild-type and mutant Dz-192) 
are somewhat surprising but not totally unexpected. The up-
stream Dz-155 not only failed to increase the cleavage activ-
ity of Rz-170 but also was catalytically inactive as no cleav-
age products were seen. It is likely that Dz-155 failed to hy-
bridize with the target RNA because of the secondary struc-
ture constraints. In this connection it is important to note that 
the ability of ODNs to successfully hybridize to the target 
RNA (as measured by RNAse H based assay) is essential but 
not sufficient for affording catalytic activity to Dz [37]. It is 
noteworthy that the hybridization arms of the Dz or Rz span 
only 14 or 16 nt (with one gap in the design) in the target 
RNA whereas the ODNs are uninterrupted 20nt long, which 
is likely to melt secondary structures better. The advantage 
of using downstream Dz would obviously be its ability to 
cleave the target RNA in a catalytic manner. A comparative 
Rz-170 mediated study between wild-type and mutant Dz-
192, suggests that the enhancement of Rz-170 cleavage is 
largely due to the antisense effects because the amounts of 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (10). Inhibition of X protein mediated HIV-1 LTR reporter gene activation with Rz + ODNs. 
293 or HepG2 cells were grown to 80% confluency in 24 well plate and then transfected with various combinations of plasmid DNAs as 
indicated + ODNs or 10-23 Dzs as shown in the bottom of the figure using 2.5μl of Lipofectin (Invitrogen) per well. 24 hours post transfec-
tion equivalent amounts of cells were subjected to lysis using 1 x reporter lysis buffer (Promega) and the extent of luciferase activity (light 
units on Y axis) was determined as described earlier (Goila & Banerjea, 2001). 
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input substrate RNA after various treatments remained the 
same. Similar intracellular level of reduction of target RNA 
was also observed with Dz-237 + ODN#5 (data not shown). 
 Although very few studies on enhanced cleavage by nu-
cleic acid approaches have earlier been reported, we report, 
for the first time, that a combination of Rz-170 and specific 
ODNs or 10-23 Dz lead to not only complete cleavage of the 
target RNA but can also cause very substantial intracellular 
reduction of X RNA. The ability of ODNs to augment in 
vitro cleavage by Rz-170 correlated with their ability to in-
terfere with the intracellular expression of the target gene. 
 In summary, we show that both Rz and Dz mediated 
cleavage of the full-length HBx RNA can be powerfully aug-
mented by specific ODNs and 10-23 Dzs. They not only 
enhanced the Rz & Dz mediated in vitro cleavage products, 
but also reduced very significantly the intracellular target 
gene expression in a mammalian liver specific cell line – 
HepG2. The intracellular effectiveness of these ODNs or 
Dzs could be substantially improved by using chemically 
modified (stabilized) nucleotide [37]. These observations are 
of immediate therapeutic importance and should be applica-
ble to down regulating other target genes also.  
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Dz = DNA-enzyme 
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